Adjuvant chemotherapy dose delivery for completely resected NSCLC in a regional cancer centre: analysis of outcomes by age and comorbidity

被引:0
|
作者
Wood, S. [1 ]
Li, R. [1 ]
Beesley, S. [1 ]
Brown, J. [1 ]
Cominos, M. [1 ]
Hall, J. [1 ]
Sevitt, T. [1 ]
Shah, R. [1 ]
Taylor, H. [1 ]
Burcombe, R. [1 ]
机构
[1] Maidstone Hlth Author, Oncol, Maidstone, Kent, England
关键词
D O I
10.1016/S0169-5002(15)50065-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
66
引用
收藏
页码:S26 / S26
页数:1
相关论文
共 50 条
  • [21] Advanced age is associated with lack of administration of adjuvant chemotherapy for completely resected stage IB-III non-small cell lung cancer (NSCLC)
    Riely, Gregory J.
    Seshan, V. E.
    Azzoli, C. G.
    Kris, Mark G.
    Rusch, Valerie W.
    Park, Bernard K.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S454 - S454
  • [22] Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC
    Shen, Zi-Qing
    Feng, Kun-Peng
    Fang, Zi-Yao
    Xia, Tian
    Pan, Shu
    Ding, Cheng
    Xu, Chun
    Ju, Sheng
    Chen, Jun
    Li, Chang
    Zhao, Jun
    JOURNAL OF CARDIOTHORACIC SURGERY, 2024, 19 (01)
  • [23] Survival Data of Postoperative Adjuvant Chemotherapy of Cisplatin plus Vinorelbine for Completely Resected NSCLC: A Retrospective Study
    Kenmotsu, Hirotsugu
    Ohde, Yasuhisa
    Ono, Akira
    Nakashima, Kazuhisa
    Omori, Shota
    Wakuda, Kazushige
    Naito, Tateaki
    Murakami, Haruyasu
    Kojima, Hideaki
    Takahashi, Shoji
    Isaka, Mitsuhiro
    Endo, Masahiro
    Takahashi, Toshiaki
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S866 - S866
  • [24] Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC
    Zi-Qing Shen
    Kun-Peng Feng
    Zi-Yao Fang
    Tian Xia
    Shu Pan
    Cheng Ding
    Chun Xu
    Sheng Ju
    Jun Chen
    Chang Li
    Jun Zhao
    Journal of Cardiothoracic Surgery, 19
  • [25] Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer
    Frueh, Martin
    Rolland, Estelle
    Pignon, Jean-Pierre
    Seymour, Lesley
    Ding, Keyue
    Tribodet, Helene
    Winton, Timothy
    Le Chevalier, Thierry
    Scagliotti, Giorgio V.
    Douillard, Jean Yves
    Spiro, Stephen
    Shepherd, Frances A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) : 3573 - 3581
  • [26] Split-dose Cisplatin and Vinorelbine as Adjuvant Chemotherapy for Completely Resected Non-small Cell Lung Cancer
    Hirai, Fumihiko
    Seto, Takashi
    Shimokawa, Mototsugu
    Inamasu, Eiko
    Toyozawa, Ryo
    Toyokawa, Gouji
    Yoshida, Tsukihisa
    Shiraishi, Yoshimasa
    Takenaka, Tomoyoshi
    Yamaguchi, Masafumi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    ANTICANCER RESEARCH, 2014, 34 (02) : 927 - 931
  • [27] Compliance with adjuvant chemotherapy for completely resected non-small cell lung cancer
    Lee, Hyun-Sung
    Kim, Moon Soo
    Lee, Jong Mog
    Kim, Heung Tae
    Zo, Jae Ill
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S480 - S480
  • [28] Adjuvant chemotherapy for completely resected non-small-cell lung cancer.
    Greco, FA
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (09): : 689 - 689
  • [29] Adjuvant chemotherapy in patients with completely resected non-small cell lung cancer
    Pirker, Robert
    TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (05) : 305 - 310
  • [30] Delivery of adjuvant chemotherapy (AC) to veterans with resected colon cancer.
    Riggs, Heather Dawn
    Lane, Kathleen A.
    Loehrer, Patrick J.
    Hui, Siu
    Rawl, Susan
    Ormerod, Anne
    Weiner, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)